Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-9.45%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$8.46B
AUM Growth
+$890M
(+12%)
Cap. Flow
+$1.63B
Cap. Flow
% of AUM
19.22%
Top 10 Holdings %
Top 10 Hldgs %
11.44%
Holding
594
New
126
Increased
220
Reduced
94
Closed
136
Top Buys
| 1 |
Cognizant
CTSH
|
$100M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$100M |
| 3 |
Microsoft
MSFT
|
$92M |
| 4 |
Becton Dickinson
BDX
|
$85.9M |
| 5 |
Exxon Mobil
XOM
|
$77.3M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$76.9M |
| 2 |
Cigna
CI
|
$73.3M |
| 3 |
HP
HPQ
|
$64.9M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
$61.8M |
| 5 |
OCR
OMNICARE INC
OCR
|
$55.1M |
Sector Composition
| 1 | Industrials | 17.58% |
| 2 | Technology | 14.89% |
| 3 | Financials | 14.61% |
| 4 | Healthcare | 13.75% |
| 5 | Energy | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNAK
276
DELISTED
Inventure Foods, Inc.
SNAK
| $3.79M | 0.04% |
426,995
-7,659
| -2% | -$68K |
|
|
ACGN
277
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $3.77M | 0.04% |
8,277
+758
| +10% | +$345K |
|
|
FOMX
278
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.74M | 0.04% |
510,191
+39,093
| +8% | +$287K |
|
279
OneMain Financial
OMF
$7.31B
| $3.73M | 0.04% |
85,402
+61,930
| +264% | +$2.71M |
|
280
A10 Networks
ATEN
$1.27B
| $3.65M | 0.04% |
609,527
-12,620
| -2% | -$75.6K |
|
281
Everest Group
EG
$14.3B
| $3.65M | 0.04% |
+21,030
| New | +$3.65M |
|
|
MJN
282
DELISTED
Mead Johnson Nutrition Company
MJN
| $3.64M | 0.04% |
+51,738
| New | +$3.64M |
|
283
Dollar General
DG
$24.1B
| $3.56M | 0.04% |
+49,198
| New | +$3.56M |
|
284
Element Solutions
ESI
$6.33B
| $3.54M | 0.04% |
279,414
+10,334
| +4% | +$131K |
|
285
Eledon Pharmaceuticals
ELDN
$162M
| $3.49M | 0.04% |
2,083
+191
| +10% | +$320K |
|
|
VR
286
DELISTED
Validus Hold Ltd
VR
| $3.43M | 0.04% |
+76,099
| New | +$3.43M |
|
|
OMED
287
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $3.43M | 0.04% |
206,483
+18,898
| +10% | +$314K |
|
288
Arcturus Therapeutics
ARCT
$485M
| $3.35M | 0.04% |
+79,339
| New | +$3.35M |
|
289
Eli Lilly
LLY
$652B
| $3.31M | 0.04% |
+39,604
| New | +$3.31M |
|
290
NN Inc
NNBR
$125M
| $3.31M | 0.04% |
179,083
-20,917
| -10% | -$387K |
|
|
TYC
291
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $3.24M | 0.04% |
92,366
+47,698
| +107% | +$1.67M |
|
292
RingCentral
RNG
$2.89B
| $3.18M | 0.04% |
174,967
-342,263
| -66% | -$6.21M |
|
293
Evercore
EVR
$12.3B
| $3.15M | 0.04% |
62,643
-385,377
| -86% | -$19.4M |
|
|
MNK
294
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $3.12M | 0.04% |
48,798
-182,930
| -79% | -$11.7M |
|
|
CNCE
295
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.05M | 0.04% |
162,534
+27,273
| +20% | +$512K |
|
|
TRNX
296
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $3.05M | 0.04% |
149,378
+128,020
| +599% | +$2.61M |
|
|
GNMK
297
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.03M | 0.04% |
384,332
+35,179
| +10% | +$277K |
|
|
INNL
298
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $3M | 0.04% |
239,912
-1,047
| -0.4% | -$13.1K |
|
299
Ares Capital
ARCC
$15.8B
| $3M | 0.04% |
+207,023
| New | +$3M |
|
300
MakeMyTrip
MMYT
$9.56B
| $3M | 0.04% |
217,987
-146,436
| -40% | -$2.01M |
|